Today the European Investment Bank (#EIB) established a collaboration with the Israel Innovation Authority and signed a €50 million financing agreement with the biotech company #Pluristem to develop stem cell therapies for #COVID-19 and other serious medical conditions.
1
20
4
41
During today’s signing ceremony, Ambassador of Israel to the EU Aharon Leshno-Yaar said: “My warmest congratulations and best wishes to Pluristem and the EIB on the occasion of the signing of the contract.
1
1
2
We are also delighted and supportive of the important collaboration between the EIB and the Israel Innovation Authority to explore additional investment opportunities in companies in the area of Bio-Convergence and health for the benefit of the whole society.”
1
3
4
“Israel has been an associated country to the European Framework Programs for more than 24 years, enabling numerous researchers and companies in the EU and Israel to cooperate in research, development, deployment and investment in pioneering technologies.”
1
2
4
“Together, we have been tackling a range of issues that matter to our societies, from health, to climate change, to the digital economy. Today, we are collectively facing what is probably the worst pandemic in a century, COVID-19.

Apr 30, 2020 · 1:15 PM UTC

1
3
4
In this battle, we must join forces – and it fills me with pride to tell you that Israel’s best researchers and entrepreneurs work tirelessly on solutions that will bring life back to normality worldwide…”
1
2
2
“In every aspect there is, #Israel is an important partner to Europe. With confidence in our innovative companies and the best of our researchers, together, we will gain the inevitable victory over the virus." #Horizon2020 #HorizonEU #EIB @ISRLInnovation #Pluristem #COVID19
4
8